John Hale, PhD

Company: BLIS Technologies

Job title: Chief Technology Officer

Seminars:

Micrococcus luteus BLIS Q24™ – Development of a Novel Skin Probiotic Strain & Formulation 3:35 pm

Characterising a new probiotic strain for skin health applications Formulating BLIS Q24™ into an appropriate topical delivery system The emerging evidence base supporting BLIS Q24™Read more

day: Day One